180 related articles for article (PubMed ID: 21520274)
1. Fracture risk in men with prostate cancer: a population-based study.
Melton LJ; Lieber MM; Atkinson EJ; Achenbach SJ; Zincke H; Therneau TM; Khosla S
J Bone Miner Res; 2011 Aug; 26(8):1808-15. PubMed ID: 21520274
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors for low trauma fractures in men with prostate cancer.
Ahlborg HG; Nguyen ND; Center JR; Eisman JA; Nguyen TV
Bone; 2008 Sep; 43(3):556-60. PubMed ID: 18585119
[TBL] [Abstract][Full Text] [Related]
3. Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications.
Shao YH; Moore DF; Shih W; Lin Y; Jang TL; Lu-Yao GL
BJU Int; 2013 May; 111(5):745-52. PubMed ID: 23331464
[TBL] [Abstract][Full Text] [Related]
4. Admissions to hospital due to fracture in England in patients with prostate cancer treated with androgen-deprivation therapy - do we have to worry about the hormones?
Jefferies ER; Bahl A; Hounsome L; Eylert MF; Verne J; Persad RA;
BJU Int; 2016 Sep; 118(3):416-22. PubMed ID: 26857695
[TBL] [Abstract][Full Text] [Related]
5. Risk of fracture in men with prostate cancer on androgen deprivation therapy: a population-based cohort study in New Zealand.
Wang A; Obertová Z; Brown C; Karunasinghe N; Bishop K; Ferguson L; Lawrenson R
BMC Cancer; 2015 Nov; 15():837. PubMed ID: 26525985
[TBL] [Abstract][Full Text] [Related]
6. Androgen deprivation therapy-related fracture risk in prostate cancer: an insurance claims database study in Japan.
Matsushima H; Taguchi T; Kodama S; Okubo N; Saito K; Jabłońska K; Fukumoto S; Matsumoto T
J Bone Miner Metab; 2024 Mar; 42(2):223-232. PubMed ID: 38493435
[TBL] [Abstract][Full Text] [Related]
7. Fracture risk in androgen deprivation therapy: a Canadian population based analysis.
Lau YK; Lee E; Prior HJ; Lix LM; Metge CJ; Leslie WD
Can J Urol; 2009 Dec; 16(6):4908-14. PubMed ID: 20003666
[TBL] [Abstract][Full Text] [Related]
8. Androgen-deprivation therapy and the risk of newly developed fractures in patients with prostate cancer: a nationwide cohort study in Korea.
Kim DK; Lee HS; Park JY; Kim JW; Ahn HK; Ha JS; Cho KS
Sci Rep; 2021 May; 11(1):10057. PubMed ID: 33980958
[TBL] [Abstract][Full Text] [Related]
9. Osteoporosis and fractures after androgen deprivation initiation for prostate cancer.
Malcolm JB; Derweesh IH; Kincade MC; DiBlasio CJ; Lamar KD; Wake RW; Patterson AL
Can J Urol; 2007 Jun; 14(3):3551-9. PubMed ID: 17594745
[TBL] [Abstract][Full Text] [Related]
10. Patients with prostate cancer and androgen deprivation therapy have increased risk of fractures-a study from the fractures and fall injuries in the elderly cohort (FRAILCO).
Wallander M; Axelsson KF; Lundh D; Lorentzon M
Osteoporos Int; 2019 Jan; 30(1):115-125. PubMed ID: 30324413
[TBL] [Abstract][Full Text] [Related]
11. Androgen deprivation therapy and fracture risk in Chinese patients with prostate carcinoma.
Lee CH; Huang G; Chan PH; Hai J; Yeung CY; Fong CH; Woo YC; Ho KL; Yiu MK; Leung F; Lau TW; Tse HF; Lam KS; Siu CW
PLoS One; 2017; 12(2):e0171495. PubMed ID: 28158241
[TBL] [Abstract][Full Text] [Related]
12. Mortality following hip fracture in men with prostate cancer.
Van Hemelrijck M; Garmo H; Michaëlsson K; Thorstenson A; Akre O; Stattin P; Holmberg L; Adolfsson J
PLoS One; 2013; 8(9):e74492. PubMed ID: 24086350
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a prognostic index for fracture risk in older men undergoing prostate cancer treatment.
Graham-Steed TR; Soulos PR; Dearing N; Concato J; Tinetti ME; Gross CP
J Geriatr Oncol; 2014 Oct; 5(4):343-51. PubMed ID: 25240918
[TBL] [Abstract][Full Text] [Related]
14. Fracture risk in Danish men with prostate cancer: a nationwide register study.
Abrahamsen B; Nielsen MF; Eskildsen P; Andersen JT; Walter S; Brixen K
BJU Int; 2007 Oct; 100(4):749-54. PubMed ID: 17822455
[TBL] [Abstract][Full Text] [Related]
15. Maintaining bone health in patients with prostate cancer.
Holmes-Walker DJ; Woo H; Gurney H; Do VT; Chipps DR
Med J Aust; 2006 Feb; 184(4):176-9. PubMed ID: 16489902
[TBL] [Abstract][Full Text] [Related]
16. Androgen deprivation therapy, diabetes and poor physical performance status increase fracture risk in Chinese men treated for prostate cancer.
Teoh JY; Chiu PK; Chan SY; Poon DM; Cheung HY; Hou SS; Ng CF
Aging Male; 2015; 18(3):180-5. PubMed ID: 26004988
[TBL] [Abstract][Full Text] [Related]
17. Incidence of fractures causing hospitalisation in prostate cancer patients: results from the population-based PCBaSe Sweden.
Thorstenson A; Bratt O; Akre O; Hellborg H; Holmberg L; Lambe M; Bill-Axelson A; Stattin P; Adolfsson J
Eur J Cancer; 2012 Jul; 48(11):1672-81. PubMed ID: 22386317
[TBL] [Abstract][Full Text] [Related]
18. Osteoporosis management program decreases incidence of hip fracture in patients with prostate cancer receiving androgen deprivation therapy.
Zhumkhawala AA; Gleason JM; Cheetham TC; Niu F; Loo RK; Dell RM; Jacobsen SJ; Chien GW
Urology; 2013 May; 81(5):1010-5. PubMed ID: 23490521
[TBL] [Abstract][Full Text] [Related]
19. Fracture risk in women with breast cancer: a population-based study.
Melton LJ; Hartmann LC; Achenbach SJ; Atkinson EJ; Therneau TM; Khosla S
J Bone Miner Res; 2012 May; 27(5):1196-205. PubMed ID: 22258822
[TBL] [Abstract][Full Text] [Related]
20. Timing of androgen deprivation therapy use and fracture risk among elderly men with prostate cancer in the United States.
Beebe-Dimmer JL; Cetin K; Shahinian V; Morgenstern H; Yee C; Schwartz KL; Acquavella J
Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):70-8. PubMed ID: 22114014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
